Eli Lilly on Tuesday issued downbeat profit and revenue guidance for the newly started year, citing in part foreign-exchange headwinds, as the drugmaker also outlined the key events expected this year for the company"s medicines in development. Shares … Read the full article on Wall Street Journal »
Eli Lilly Issues Weak 2016 Financial Outlook - Wall Street Journal
No comments:
Post a Comment